Skip to main content
main-content

Type 2 diabetes

Highlights

10-12-2020 | Ertugliflozin | Highlight | News

VERTIS CV secondary analyses indicate ertugliflozin protection against HF

Secondary analysis of the VERTIS CV trial supports a significant protective effect of ertugliflozin on risk for heart failure in people with type 2 diabetes, despite the overall neutral outcome of the trial.

08-19-2020 | Metabolic surgery | Highlight | News

‘Nearly identical’ metabolic benefits with surgery vs diet in people with type 2 diabetes

Among people with obesity and type 2 diabetes, substantial weight loss is associated with similar metabolic benefits irrespective of whether it is achieved through gastric bypass surgery or diet, suggests research published in The New England Journal of Medicine.

08-17-2020 | COVID-19 | Highlight | News

Type 1, type 2 diabetes linked to elevated COVID-19 mortality risk

Both type 1 and type 2 diabetes are independently associated with an increased risk for death among hospitalized patients with COVID-19, and a number of factors including poor glycemic control and BMI may predict mortality risk, suggest findings from two studies published in The Lancet Diabetes & Endocrinology.

08-11-2020 | Ethnic groups | Highlight | News

Ethnic-specific diabetes screening BMI cutoffs proposed

Researchers studying the MESA cohort have proposed BMI cutoffs at which people from ethnic minorities should be screened for type 2 diabetes, all of which are lower than their proposed cutoff for White people.

08-03-2020 | Hypoglycemia | Highlight | News

Severe hypoglycemia ‘marker rather than cause’ for longer-term type 2 diabetes mortality risk

Severe hypoglycemia in people with type 2 diabetes is associated with later mortality from a wide range of causes, including those for which there is no obvious underlying mechanism, say researchers.

07-17-2020 | Type 2 diabetes | Highlight | News

Nonvascular comorbidities highlighted in type 2 diabetes

A large study of data from people with type 2 diabetes in general practice reveals that non-cardiovascular comorbidities such as osteoarthritis and depression are common, and significantly more so than in people without diabetes.

07-10-2020 | Prediabetes | Highlight | News

Key danger times identified for US Diabetes Prevention Program dropout

Focusing efforts on convincing people to return after the first session of the US National Diabetes Prevention Program lifestyle change program, and after the transition to less frequent sessions, may help to optimize program retention, say researchers.

07-02-2020 | Prediabetes | Highlight | News

Neighborhood walkability may reduce ethnic disparities in diabetes risk

The increased risk for prediabetes among ethnic minorities compared with White people is less pronounced in neighborhoods with high walkability, shows a Canadian study.

06-05-2020 | Ethnic groups | Highlight | News

‘Compelling evidence’ of greater diabetes treatment inertia for ethnic minorities

Doctors are faster to initiate pharmacologic type 2 diabetes treatment in people from ethnic minorities than in White people but are then slower to intensify their treatment when needed, show data from the UK.

06-01-2020 | Risk factors | Highlight | News

Cardiometabolic burden varies by age, sex, ethnicity at type 2 diabetes diagnosis

A study shows marked variations in cardiovascular risk burden according to age, sex, and ethnicity at the point of type 2 diabetes diagnosis, with implications for both diabetes prevention and cardiovascular risk management.

05-06-2020 | Genetics | Highlight | News

Genetic markers of type 2 diabetes risk in East Asian people uncovered

A major genetic analysis sheds light on the similarities and differences in type 2 diabetes pathogenesis between people of East Asian and European origin.

05-05-2020 | Prediabetes | Highlight | News

Prediabetes marks increased vascular risk

People who meet the criteria for prediabetes during the 3 years before a type 2 diabetes diagnosis have a higher burden of vascular disease than those who do not, research shows.

04-24-2020 | Semaglutide | Highlight | News

PIONEER 9, 10 confirm oral semaglutide efficacy in Japanese population

Results of the PIONEER 9 and 10 trials show that oral semaglutide is efficacious in Japanese people with type 2 diabetes.

04-16-2020 | Nephropathy | Highlight | News

Hypoglycemia risk with even mild renal dysfunction in real-world practice

A large observational study reveals a strong link between reduced kidney function and increased incidence of hypoglycemia in adults with diabetes in routine clinical practice.

04-09-2020 | Metformin | Highlight | News

Preoperative metformin use associated with better outcomes after major surgery

People with type 2 diabetes who are treated with metformin prior to undergoing major surgical interventions may have better postoperative outcomes than those without exposure to the drug, researchers report.

04-06-2020 | Heart failure | Highlight | News

Exercise better than diet to combat early heart changes in type 2 diabetes

The results of a small randomized trial suggest exercise is more helpful than diet for combating early cardiac dysfunction associated with type 2 diabetes, although both may be beneficial.

03-31-2020 | SGLT2 inhibitors | Highlight | News

Cardioprotective benefits of dapagliflozin extend beyond people with diabetes

Treatment with dapagliflozin is associated with a significant reduction in the risk for heart failure worsening or cardiovascular death in people with heart failure and reduced ejection fraction regardless of whether or not they have diabetes, shows an exploratory analysis of DAPA-HF trial data.

03-24-2020 | Older adults | Highlight | News

Diabetes medication changes at hospital discharge of older adults often not beneficial

Older adults with type 2 diabetes often receive diabetes medication adjustments at hospital discharge that may be of little or no benefit, study results suggest.

03-11-2020 | Liraglutide (obesity) | Highlight | News

Liraglutide 3.0 mg boosts weight loss in insulin-dependent type 2 diabetes

Adding liraglutide 3.0 mg to intensive behavioral therapy increases weight loss in overweight or obese people with insulin-treated type 2 diabetes, results of the phase 3 SCALE Insulin trial show.

02-26-2020 | Coronary artery disease | Highlight | News

Urgent action needed to improve dysglycemia screening in patients with heart disease

More than half of people with coronary artery disease have impaired glucose tolerance, yet many are unaware of this or are undertreated despite knowledge of their condition, results of the EUROASPIRE V survey show.

Image Credits